Kanabo Group Appoints Ian Mattioli as Chair of the Board and Secures a £2.5M Minimum Investment Round
Digital Health Global
MAY 9, 2023
Since its inception in 2017, Kanabo has focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. In March 2023, Kanabo successfully launched its pain clinic, Treat It, under the expert guidance of its technological and product expertise.
Let's personalize your content